Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Autolus Therapeutics Ltd. buy melinda

Start price
€5.30
12.03.20 / 30%
Target price
-
04.11.21
Performance (%)
-12.08%
End price
€4.66
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €4.66. The prediction for Autolus Therapeutics Ltd. disappointed with a performance of -12.08%. melinda has a follow-up prediction for Autolus Therapeutics Ltd. where he still thinks Autolus Therapeutics Ltd. is a Buy. melinda has 30% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Autolus Therapeutics Ltd. - - - -
iShares Core DAX® 1.662% 4.835% 17.361% 19.329%
iShares Nasdaq 100 0.667% 0.000% 38.234% 55.157%
iShares Nikkei 225® -2.139% -4.786% 13.099% 7.393%
iShares S&P 500 0.564% 0.775% 29.181% 46.527%

According to melinda what are the pros and cons of Autolus Therapeutics Ltd. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Autolus Therapeutics Ltd. diskutieren
Prediction Buy
Perf. (%) -12.08%
Target price 10.000
Change
Ends at 04.11.21

Buy mit Kursziel 10,0

Prediction Buy
Perf. (%) -12.08%
Target price
Change
Ends at 04.11.21

Kursziel geändert auf 0,0

In the thread Trading Autolus Therapeutics Ltd.
Prediction Buy
Perf. (%) -12.08%
Target price
Change
Ends at 04.11.21

Die von melinda gewählte maximale Laufzeit wurde überschritten

Current prediction by melinda for Autolus Therapeutics Ltd.

buy
Autolus Therapeutics Ltd.

Start price
Target price
Perf. (%)
€6.00
27.12.23
€7.50
27.12.24
-39.00%
14.05.24

Could be worthwhile Investment >10% per year

Stopped prediction by melinda for Autolus Therapeutics Ltd.

buy
Autolus Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.93
15.11.22
-
15.11.23
106.22%
16.11.23

Could be worthwhile Investment >10% per year